Heart Failure and Heart Transplant Program, Department of Specialist, Diagnostic, and Experimental Medicine, Policlinico S.Orsola-Malpighi, Alma-Mater University of Bologna, Bologna, Italy.
Heart Transplant Program, Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione (ISMETT), Palermo, Italy.
J Heart Lung Transplant. 2017 Nov;36(11):1217-1225. doi: 10.1016/j.healun.2017.02.014. Epub 2017 Feb 17.
Primary graft dysfunction (P-GD) is the leading cause of early mortality after heart transplantation (HT). In this 2-center study we analyze outcomes and risk factors of P-GD according to the recent consensus conference classification endorsed by International Society for Heart and Lung Transplantation.
We included all adult HTs performed between 1999 and 2013. P-GD was graded as mild, moderate, and severe, according to International Society for Heart and Lung Transplantation recommendations, and analyzed separately from secondary GD. The primary end point was the combined occurrence of in-hospital death or emergency retransplantation.
Early GD was found in 118 of 518 patients (23%), and 72 (13.9%) met the criteria for P-GD. Of these, 4 (5%) were mild, 33 (46%) moderate, and 35 (49%) severe and mostly characterized by biventricular involvement (78%). The end point occurred in 53 patients (10.2%). Overall, GD was a strong predictor of death-graft loss (odds ratio, 15.9; 95% confidence interval, 7.9-33.5; p < 0.01), with non-significant worse outcomes in P-GD (37%) vs secondary GD (27%) patients (p = 0.2). The study end point was more frequent in severe P-GD patients (65%) than in moderate (12%) or mild (0%; p < 0.01). Several known risk factors influenced the risk for P-GD, and the combination of specific donor and recipient risk factors accounted for approximately 22-times increased odds for P-GD. Donor age, recipient diabetes, ischemic time, and post-operative dialysis predicted non-recovery from P-GD.
Consensus-defined P-GD identifies patients at major risk for early death and graft loss after HT, although the "mild" grade appeared under-represented and clinically irrelevant. The amplified negative effect of donor and recipient factors on P-GD risk underscores the need for appropriate donor-recipient match.
原发性移植物功能障碍(PGD)是心脏移植(HT)后早期死亡的主要原因。在这项由两个中心进行的研究中,我们根据国际心肺移植学会(ISHLT)认可的最近的共识会议分类来分析 PGD 的结果和危险因素。
我们纳入了 1999 年至 2013 年期间进行的所有成人 HT。根据 ISHLT 的建议,将 PGD 分为轻度、中度和重度,并分别与继发性 GD 进行分析。主要终点是住院期间死亡或紧急再次移植的联合发生。
在 518 例患者中有 118 例(23%)出现早期 GD,其中 72 例(13.9%)符合 PGD 的标准。其中,4 例(5%)为轻度,33 例(46%)为中度,35 例(49%)为重度,且主要表现为双心室受累(78%)。终点事件发生在 53 例患者(10.2%)中。总体而言,GD 是死亡-移植物丢失的强有力预测因素(优势比,15.9;95%置信区间,7.9-33.5;p < 0.01),PGD 患者(37%)的结局并不比继发性 GD 患者(27%)差(p = 0.2)。严重 PGD 患者(65%)的研究终点比中度(12%)或轻度(0%)患者更常见(p < 0.01)。几个已知的危险因素影响 PGD 的风险,特定的供体和受体危险因素的组合占 PGD 风险增加约 22 倍。供体年龄、受体糖尿病、缺血时间和术后透析预测 PGD 无法恢复。
共识定义的 PGD 确定了 HT 后早期死亡和移植物丢失的高危患者,尽管“轻度”等级似乎代表性不足且临床意义不大。供体和受体因素对 PGD 风险的放大负面影响突出表明需要进行适当的供体-受体匹配。